Voya Investment Management LLC Has $4.01 Million Stock Holdings in Phreesia, Inc. (NYSE:PHR)

Voya Investment Management LLC trimmed its position in shares of Phreesia, Inc. (NYSE:PHR - Free Report) by 9.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 159,274 shares of the company's stock after selling 16,393 shares during the period. Voya Investment Management LLC owned approximately 0.27% of Phreesia worth $4,007,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Greenhouse Funds LLLP boosted its stake in Phreesia by 27.9% during the 4th quarter. Greenhouse Funds LLLP now owns 2,873,892 shares of the company's stock valued at $72,307,000 after purchasing an additional 626,579 shares during the period. ExodusPoint Capital Management LP boosted its position in shares of Phreesia by 448.6% in the fourth quarter. ExodusPoint Capital Management LP now owns 174,971 shares of the company's stock valued at $4,402,000 after acquiring an additional 143,077 shares during the period. Barclays PLC grew its stake in shares of Phreesia by 120.4% in the fourth quarter. Barclays PLC now owns 209,209 shares of the company's stock worth $5,264,000 after acquiring an additional 114,280 shares during the last quarter. Norges Bank bought a new position in Phreesia during the fourth quarter worth $2,804,000. Finally, Nicholas Company Inc. acquired a new position in Phreesia during the 4th quarter valued at $2,452,000. 92.10% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Phreesia news, insider Yvonne Hui sold 1,878 shares of the company's stock in a transaction on Tuesday, April 8th. The stock was sold at an average price of $23.85, for a total transaction of $44,790.30. Following the transaction, the insider now owns 28,449 shares of the company's stock, valued at approximately $678,508.65. This represents a 6.19 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Evan Roberts sold 3,519 shares of the firm's stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $30.06, for a total value of $105,781.14. Following the completion of the transaction, the chief operating officer now owns 741,197 shares in the company, valued at approximately $22,280,381.82. This represents a 0.47 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 112,660 shares of company stock worth $3,124,263 in the last three months. Insiders own 5.80% of the company's stock.

Phreesia Price Performance

PHR stock traded down $0.46 during trading on Monday, hitting $25.26. 287,386 shares of the stock traded hands, compared to its average volume of 430,387. Phreesia, Inc. has a one year low of $17.07 and a one year high of $30.53. The company has a 50 day simple moving average of $25.22 and a 200 day simple moving average of $24.57. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The stock has a market cap of $1.48 billion, a price-to-earnings ratio of -17.18 and a beta of 0.74.

Analyst Upgrades and Downgrades

PHR has been the topic of several research reports. DA Davidson dropped their price objective on shares of Phreesia from $36.00 to $34.00 and set a "buy" rating on the stock in a report on Monday, April 14th. Piper Sandler reaffirmed an "overweight" rating and issued a $33.00 price target (up previously from $31.00) on shares of Phreesia in a report on Wednesday, January 29th. Canaccord Genuity Group lifted their price objective on Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a report on Thursday, March 13th. Needham & Company LLC restated a "buy" rating and set a $29.00 price objective on shares of Phreesia in a research report on Thursday, March 13th. Finally, Royal Bank of Canada raised Phreesia from a "sector perform" rating to an "outperform" rating and raised their target price for the stock from $24.00 to $32.00 in a research report on Wednesday, January 8th. Twelve investment analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has an average rating of "Buy" and a consensus price target of $31.33.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.